Advertisement
News
Advertisement

pSivida expands into orthopedics, eyes FDA ruling

Wed, 08/17/2011 - 10:51am
Mass High Tech: The Journal of New England Technology

Watertown drug-delivery company pSivida Corp. is expanding beyond eye treatments into orthopedics with an evaluation agreement with Hospital for Special Surgery in New York.

Company president and CEO Paul Ashton also said the company expects the U.S. Food and Drug Administration (FDA) to rule on its Iluvien treatment for diabetic macular edema, the leading cause of blindness in diabetics under age 65, by Nov. 12. The company’s partner, Alimera Sciences Inc., resubmitted a new drug application in May.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading